Sep 01, 2023 7:30am EDT Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
Aug 03, 2023 7:30am EDT Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid
Jul 18, 2023 7:30am EDT Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities
May 04, 2023 7:30am EDT Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park
Apr 19, 2023 7:30am EDT Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
Mar 10, 2023 5:17pm EST Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Mar 08, 2023 8:55am EST Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Mar 07, 2023 7:30am EST Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
Feb 07, 2023 8:30am EST Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)
